Belarus vs Montenegro: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Belarus
16.0%
in 2025
Montenegro
28.0%
in 2025
Belarus rank
163rd
Montenegro rank
160th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Belarus
- Montenegro
How they compare
Montenegro currently reports 28.0% against 16.0% in Belarus, a difference of 12.0%.
That makes Montenegro's figure about 1.8 times Belarus's.
Across all 18 years both countries report, Montenegro has been ahead every year.
Belarus ranks 163rd and Montenegro ranks 160th of 192 countries.
Montenegro has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belarus | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 2.7% | 4.7% | 2.0% | Montenegro |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Belarus or Montenegro?
- Montenegro, at 28.0% against 16.0% in Belarus as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Belarus and Montenegro?
- 12.0%, with Montenegro ahead.
- How many years of comparable data are there for Belarus and Montenegro?
- 18 years are reported by both, from 2008 to 2025.
- How do Belarus and Montenegro rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Belarus ranks 163rd and Montenegro ranks 160th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.